These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12857416)

  • 21. Fetal tissue engineering: in vitro analysis of muscle constructs.
    Fuchs JR; Pomerantseva I; Ochoa ER; Vacanti JP; Fauza DO
    J Pediatr Surg; 2003 Sep; 38(9):1348-53. PubMed ID: 14523818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Living patches engineered from human umbilical cord derived fibroblasts and endothelial progenitor cells.
    Schmidt D; Mol A; Neuenschwander S; Breymann C; Gössi M; Zund G; Turina M; Hoerstrup SP
    Eur J Cardiothorac Surg; 2005 May; 27(5):795-800. PubMed ID: 15848316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transforming growth factor β, bone morphogenetic protein, and vascular endothelial growth factor mediate phenotype maturation and tissue remodeling by embryonic valve progenitor cells: relevance for heart valve tissue engineering.
    Chiu YN; Norris RA; Mahler G; Recknagel A; Butcher JT
    Tissue Eng Part A; 2010 Nov; 16(11):3375-83. PubMed ID: 20629541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum derived from multiple trauma patients promotes the differentiation of endothelial progenitor cells in vitro: possible role of transforming growth factor-beta1 and vascular endothelial growth factor165.
    Henrich D; Hahn P; Wahl M; Wilhelm K; Dernbach E; Dimmeler S; Marzi I
    Shock; 2004 Jan; 21(1):13-6. PubMed ID: 14676678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioactive porcine matrices in heart valve tissue engineering.
    Somers P; de Somer F; Cornelissen M; Thierens H; Van Nooten G
    J Heart Valve Dis; 2012 Jul; 21(4):535-43. PubMed ID: 22953684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Construction of an autologous tissue-engineered venous conduit from bone marrow-derived vascular cells: optimization of cell harvest and seeding techniques.
    Roh JD; Brennan MP; Lopez-Soler RI; Fong PM; Goyal A; Dardik A; Breuer CK
    J Pediatr Surg; 2007 Jan; 42(1):198-202. PubMed ID: 17208565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiogenic modulators in valve development and disease: does valvular disease recapitulate developmental signaling pathways?
    Shworak NW
    Curr Opin Cardiol; 2004 Mar; 19(2):140-6. PubMed ID: 15075741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opposite effects of transforming growth factor-β1 and vascular endothelial growth factor on the degeneration of aortic valvular interstitial cell are modified by the extracellular matrix protein fibronectin: implications for heart valve engineering.
    Gwanmesia P; Ziegler H; Eurich R; Barth M; Kamiya H; Karck M; Lichtenberg A; Akhyari P
    Tissue Eng Part A; 2010 Dec; 16(12):3737-46. PubMed ID: 20673026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endothelial progenitor cells as a sole source for ex vivo seeding of tissue-engineered heart valves.
    Sales VL; Mettler BA; Engelmayr GC; Aikawa E; Bischoff J; Martin DP; Exarhopoulos A; Moses MA; Schoen FJ; Sacks MS; Mayer JE
    Tissue Eng Part A; 2010 Jan; 16(1):257-67. PubMed ID: 19698056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chondrogenic differentiation of human adipose-derived stem cells in polyglycolic acid mesh scaffolds under dynamic culture conditions.
    Mahmoudifar N; Doran PM
    Biomaterials; 2010 May; 31(14):3858-67. PubMed ID: 20153043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Umbilical cord blood derived endothelial progenitor cells for tissue engineering of vascular grafts.
    Schmidt D; Breymann C; Weber A; Guenter CI; Neuenschwander S; Zund G; Turina M; Hoerstrup SP
    Ann Thorac Surg; 2004 Dec; 78(6):2094-8. PubMed ID: 15561042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evolution of cell phenotype and extracellular matrix in tissue-engineered heart valves during in-vitro maturation and in-vivo remodeling.
    Rabkin E; Hoerstrup SP; Aikawa M; Mayer JE; Schoen FJ
    J Heart Valve Dis; 2002 May; 11(3):308-14; discussion 314. PubMed ID: 12056720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proliferation and differentiation of rat bone marrow stromal cells on poly(glycolic acid)-collagen sponge.
    Fujita M; Kinoshita Y; Sato E; Maeda H; Ozono S; Negishi H; Kawase T; Hiraoka Y; Takamoto T; Tabata Y; Kameyama Y
    Tissue Eng; 2005; 11(9-10):1346-55. PubMed ID: 16259590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of growth factor treatment on meniscal chondrocyte proliferation and differentiation on polyglycolic acid scaffolds.
    Stewart K; Pabbruwe M; Dickinson S; Sims T; Hollander AP; Chaudhuri JB
    Tissue Eng; 2007 Feb; 13(2):271-80. PubMed ID: 17504061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perfusion culture enhances osteogenic differentiation of rat mesenchymal stem cells in collagen sponge reinforced with poly(glycolic Acid) fiber.
    Hosseinkhani H; Inatsugu Y; Hiraoka Y; Inoue S; Tabata Y
    Tissue Eng; 2005; 11(9-10):1476-88. PubMed ID: 16259602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Minimally-invasive implantation of living tissue engineered heart valves: a comprehensive approach from autologous vascular cells to stem cells.
    Schmidt D; Dijkman PE; Driessen-Mol A; Stenger R; Mariani C; Puolakka A; Rissanen M; Deichmann T; Odermatt B; Weber B; Emmert MY; Zund G; Baaijens FP; Hoerstrup SP
    J Am Coll Cardiol; 2010 Aug; 56(6):510-20. PubMed ID: 20670763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Engineering of implantable cartilaginous structures from bone marrow-derived mesenchymal stem cells.
    Hannouche D; Terai H; Fuchs JR; Terada S; Zand S; Nasseri BA; Petite H; Sedel L; Vacanti JP
    Tissue Eng; 2007 Jan; 13(1):87-99. PubMed ID: 17518583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A small diameter elastic blood vessel wall prepared under pulsatile conditions from polyglycolic acid mesh and smooth muscle cells differentiated from adipose-derived stem cells.
    Wang C; Cen L; Yin S; Liu Q; Liu W; Cao Y; Cui L
    Biomaterials; 2010 Feb; 31(4):621-30. PubMed ID: 19819545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Composite implantation of mesenchymal stem cells with endothelial progenitor cells enhances tissue-engineered bone formation.
    Usami K; Mizuno H; Okada K; Narita Y; Aoki M; Kondo T; Mizuno D; Mase J; Nishiguchi H; Kagami H; Ueda M
    J Biomed Mater Res A; 2009 Sep; 90(3):730-41. PubMed ID: 18570318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prenatally engineered autologous amniotic fluid stem cell-based heart valves in the fetal circulation.
    Weber B; Emmert MY; Behr L; Schoenauer R; Brokopp C; Drögemüller C; Modregger P; Stampanoni M; Vats D; Rudin M; Bürzle W; Farine M; Mazza E; Frauenfelder T; Zannettino AC; Zünd G; Kretschmar O; Falk V; Hoerstrup SP
    Biomaterials; 2012 Jun; 33(16):4031-43. PubMed ID: 22421386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.